Cargando…
ODP461 Amiodarone Induced Thyrotoxicosis With Severe Cardiac Disease Refractory to Medical Therapy and Plasmapheresis
INTRODUCTION: Management of amiodarone induced thyrotoxicosis (AIT) presents the clinical challenge of differentiating between the two subtypes: Type I AIT, characterized by increased hormonal biosynthesis, and Type II AIT, a destructive thyroiditis since the treatment differs. We present a case of...
Autores principales: | Ravin, Andrew, Figueroa, Jonathan, Cheng, Jennifer, Elmedani, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625505/ http://dx.doi.org/10.1210/jendso/bvac150.1562 |
Ejemplares similares
-
THU654 The Use Of Plasmapheresis In A Severe Case Of Amiodarone Induced Thyrotoxicosis
por: Moazezi, Tina, et al.
Publicado: (2023) -
ODP462 Amiodarone Induced Thyrotoxicosis-Treatment Challenges
por: Firak, Gabriela, et al.
Publicado: (2022) -
THU659 Plasmapheresis As A Therapy For Amiodarone-induced Thyrotoxicosis: A Case Report And Literature Review
por: Loughner, Chelsea L, et al.
Publicado: (2023) -
SAT483 Role of Cholestyramine in Refractory Amiodarone-induced Thyrotoxicosis
por: Zhao, Huaying, et al.
Publicado: (2023) -
Amiodarone Induced Thyrotoxicosis: A Case of Refractory Disease Treated With Thyroidectomy
por: Mushref, Malek, et al.
Publicado: (2021)